Haimen Pharma Inc

General

Total Cases2
Active Cases2
Patents1
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
09/25/24
SUMMONS ISSUED as to HAIMEN PHARMA INC., SINOTHERAPEUTICS INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) (Entered: 09/25/2024)
09/25/24
AO120 Patent/Trademark Form filed. (kht) (Entered: 09/25/2024)
09/25/24
Judge Michael A. Shipp and Magistrate Judge Rukhsanah L. Singh added. (kht) (Entered: 09/25/2024)
09/24/24
Corporate Disclosure Statement by ASTELLAS PHARMA INC., ASTELLAS PHARMA US, INC., ASTELLAS US LLC, MEDIVATION LLC, MEDIVATION PROSTATE THERAPEUTICS LLC, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA. (WALSH, LIZA) (Entered: 09/24/2024)
09/24/24
Corporate Disclosure Statement by ASTELLAS PHARMA INC., ASTELLAS PHARMA US, INC., ASTELLAS US LLC, MEDIVATION LLC, MEDIVATION PROSTATE THERAPEUTICS LLC, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA. (WALSH, LIZA) (Entered: 09/24/2024)
09/24/24
COMPLAINT against HAIMEN PHARMA INC., SINOTHERAPEUTICS INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15688222) , Related Case Selected, filed by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, ASTELLAS PHARMA US, INC., ASTELLAS US LLC, ASTELLAS PHARMA INC., MEDIVATION LLC, MEDIVATION PROSTATE THERAPEUTICS LLC. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Civil Cover Sheet, # [4] AO 120 Form)(WALSH, LIZA) (Entered: 09/24/2024)
09/24/24
COMPLAINT against HAIMEN PHARMA INC., SINOTHERAPEUTICS INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15688222) , Related Case Selected, filed by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, ASTELLAS PHARMA US, INC., ASTELLAS US LLC, ASTELLAS PHARMA INC., MEDIVATION LLC, MEDIVATION PROSTATE THERAPEUTICS LLC. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Civil Cover Sheet, # [4] AO 120 Form)(WALSH, LIZA) (Entered: 09/24/2024)